Sierra Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-191
Closed -$6K 700
2022
Q2
$6K Hold
191
﹤0.01% 474
2022
Q1
$7K Sell
191
-163
-46% -$5.57K ﹤0.01% 512
2021
Q4
$11K Buy
354
+145
+69% +$4.72K ﹤0.01% 474
2021
Q3
$7K Sell
209
-101
-33% -$3.23K ﹤0.01% 409
2021
Q2
$9K Buy
+310
New +$10.2K ﹤0.01% 386

Other funds holding OGN

Sierra Capital's OGN Position: Q3 2022 in Review

Sierra Capital sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 191 shares — an estimated $6K sold.

Sierra Capital first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $11K in Q4 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Sierra Capital reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Sierra Capital sold 191 Organon & Co shares in Q3 2022, an estimated $6K.
  • Sierra Capital first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Sierra Capital's Organon & Co position peaked at $11K in Q4 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Sierra Capital's 13F filing for Q3 2022, filed 4 Nov 2022.